| Financial Year |
March 31 2023 |
| Monetary Funds |
729,414,672.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
34,553,100.42 |
| Accounts Receivable |
998,472,048.80 |
| Advances to Suppliers |
51,065,512.00 |
| Other Receivables |
43,160,658.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
369,919.74 |
| Inventories |
687,571,655.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,552,937,090.06 |
| Total Current Assets |
6,098,735,977.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,667,902.87 |
| Investment Properties |
2,882,361.11 |
| Fixed Assetes |
1,962,327,468.70 |
| Under-construction Projects |
1,445,945,604.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
197,595,530.58 |
| R&D expenses |
-- |
| Goodwill |
164,648,504.26 |
| Long-Term Deferred and Prepaid Expenses |
69,000,990.63 |
| Deferred Income Tax Assets |
252,921,374.23 |
| Other Non-Current Assets |
235,271,064.00 |
| Sub-Total of Non-Current Assets |
4,413,636,578.28 |
| Total Assets |
10,512,372,555.85 |
| Short-Term Loans |
175,048,888.81 |
| Trading Financial liabilities |
20,000.00 |
| Notes Payable |
439,000,000.00 |
| Accounts Payable |
277,172,415.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,344,154.17 |
| Taxes Payable |
124,006,130.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
558,718,712.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
75,424,873.05 |
| Other Current Liabilities |
91,379,337.52 |
| Sub-Total of Current Liabilities |
1,839,956,949.12 |
| Long-term Loans |
115,074,555.55 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,309,473.98 |
| Deferred Income Tax Liabilities |
266,078,360.50 |
| Other Non-Current Liabilities |
75,912,720.21 |
| Sub-Total of Non-Current Liabilities |
513,182,773.99 |
| Total Liabilities |
2,353,139,723.11 |
| Paid-In Capital(Or Share Stock) |
586,272,256.00 |
| Capital Surplus |
4,100,916,401.24 |
| Surplus Reserve |
293,162,011.78 |
| LESS:Treasury Stock |
243,300,008.68 |
| Undistributed Profits |
3,287,005,763.53 |
| Minority Stockholder's Interest |
134,691,253.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,024,541,579.52 |
| Owner's Equity（Stockholder's Equity） |
8,159,232,832.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,512,372,555.85 |
